| Plasma biomarker for detection of early stage pancreatic cancer and risk factors for pancreatic malignancy using antibodies for apolipoprotein-AII isoforms K Honda, M Kobayashi, T Okusaka, JA Rinaudo, Y Huang, T Marsh, ... Scientific reports 5 (1), 15921, 2015 | 86 | 2015 |
| Validation of models used to inform colorectal cancer screening guidelines: accuracy and implications CM Rutter, AB Knudsen, TL Marsh, VP Doria-Rose, E Johnson, ... Medical Decision Making 36 (5), 604-614, 2016 | 70 | 2016 |
| A plasma biomarker panel to identify surgically resectable early-stage pancreatic cancer S Balasenthil, Y Huang, S Liu, T Marsh, J Chen, SA Stass, D KuKuruga, ... JNCI: Journal of the National Cancer Institute 109 (8), djw341, 2017 | 68 | 2017 |
| Statistical approaches to group sequential monitoring of postmarket safety surveillance data: current state of the art for use in the Mini‐Sentinel pilot AJ Cook, RC Tiwari, RD Wellman, SR Heckbert, L Li, P Heagerty, T Marsh, ... Pharmacoepidemiology and drug safety 21, 72-81, 2012 | 64 | 2012 |
| Blood-based biomarker panel for personalized lung cancer risk assessment JF Fahrmann, T Marsh, E Irajizad, N Patel, E Murage, J Vykoukal, ... Journal of Clinical Oncology 40 (8), 876-883, 2022 | 50 | 2022 |
| Vaccination site and risk of local reactions in children 1 through 6 years of age LA Jackson, D Peterson, JC Nelson, SM Marcy, AL Naleway, JD Nordin, ... Pediatrics 131 (2), 283-289, 2013 | 32 | 2013 |
| Multicenter validation of abbreviated MRI for detecting early-stage hepatocellular carcinoma T Yokoo, N Masaki, ND Parikh, BF Lane, Z Feng, M Mendiratta-Lala, ... Radiology 307 (2), e220917, 2023 | 29 | 2023 |
| Statistical inference for net benefit measures in biomarker validation studies TL Marsh, H Janes, MS Pepe Biometrics 76 (3), 843-852, 2020 | 20 | 2020 |
| Can neurons distinguish chaos from noise? JF Lindner, BK Meadows, TL Marsh, WL Ditto, AR Bulsara International Journal of Bifurcation and Chaos 8 (04), 767-781, 1998 | 16 | 1998 |
| The importance of uncertainty and opt-in v. opt-out: best practices for decision curve analysis KF Kerr, TL Marsh, H Janes Medical Decision Making 39 (5), 491-492, 2019 | 14 | 2019 |
| Assessing the clinical impact of risk models for opting out of treatment KF Kerr, MD Brown, TL Marsh, H Janes Medical Decision Making 39 (2), 86-90, 2019 | 14 | 2019 |
| Validation sampling can reduce bias in health care database studies: an illustration using influenza vaccination effectiveness JC Nelson, T Marsh, T Lumley, EB Larson, LA Jackson, ML Jackson, ... Journal of clinical epidemiology 66 (8), S110-S121, 2013 | 14 | 2013 |
| Hölder compactification for some manifolds with pinched negative curvature near infinity E Bahuaud, T Marsh Canadian Journal of Mathematics 60 (6), 1201-1218, 2008 | 14 | 2008 |
| GALAD score improves early detection of hcc prior to the diagnosis of hcc: a phase 3 biomarker validation study JA Marrero, TL Marsh, ND Parikh, LR Roberts, ME Schwartz, MH Nguyen, ... Hepatology 74, 92A-93A, 2021 | 12 | 2021 |
| Mortality benefit of a blood-based biomarker panel for lung cancer on the basis of the prostate, lung, colorectal, and ovarian cohort E Irajizad, JF Fahrmann, T Marsh, J Vykoukal, JB Dennison, JP Long, ... Journal of Clinical Oncology 41 (27), 4360-4368, 2023 | 10 | 2023 |
| Incidence and risk factors for hepatocellular carcinoma in cirrhosis: the multicenter hepatocellular carcinoma early detection strategy (HEDS) study KR Reddy, D McLerran, T Marsh, N Parikh, LR Roberts, M Schwartz, ... Gastroenterology 165 (4), 1053-1063. e6, 2023 | 8 | 2023 |
| Low prevalence of screen-detected colorectal cancer in an average-risk population: the new normal A Shaukat, TL Marsh, SD Crockett, S Syngal, RS Bresalier, DE Brenner, ... Clinical gastroenterology and hepatology: the official clinical practice …, 2022 | 6 | 2022 |
| Statistical methods for estimating causal risk differences in the distributed data setting for postmarket safety outcomes AJ Cook, RD Wellman, T Marsh, RC Tiwari, MD Nguyen, ... Mini‐Sentinel report, 2012 | 6 | 2012 |
| Mini-Sentinel methods development: Statistical methods for estimating causal risk differences in the distributed data setting for postmarket safety outcomes AJ Cook, RD Wellman, T Marsh, RC Tiwari, MD Nguyen, ... FDA’s Sentinel Initiative: Project Report, 2012 | 6 | 2012 |
| Demonstrate feasibility of new Mini-Sentinel group sequential monitoring methods in a distributed setting by implementing them in practice: Report of the Mini-Sentinel Group … AJ Cook, RD Wellman, A Shaoibi, RC Tiwari, D Boudreau, ... | 3 | 2013 |
